The machine learning methods aid to choose ezetimibe or statins for ischemic stroke patients with SLCO1B1 variants
The ezetimibe group had a lower rate of recurrence and side effects, a higher rate of recommended LDL-C level, and a similar unfavorable functional outcome. For male, younger stroke patients with SLCO1B1 variants, higher blood pressure, and blood lipid using ezetimibe are related to a better prognosis than other patients.
Authors
- Tonghua Long
- Chaohua Cui
- Qiulian Yin
- Haoye Guan
Institutions
- Affiliated Hospital of Youjiang Medical University for Nationalities (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1186/s40001-025-03738-2
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00